Risk factors associated with fasting during Ramadan among individuals with diabetes according to IDF-DAR risk score in Atbara city, Sudan: Cross-sectional hospital-based study.

Autor: Noor SK; Department of Medicine, Faculty of Medicine, Nile Valley University, Atabara, Sudan., Alutol MT; Department of Medicine, Faculty of Medicine, Nile Valley University, Atabara, Sudan., FadAllah FSA; Department of Medicine, Faculty of Medicine, Nile Valley University, Atabara, Sudan., Ahmed AA; Department of Medicine, Faculty of Medicine, Nile Valley University, Atabara, Sudan., Osman SA; Department of Medicine, Faculty of Medicine, Nile Valley University, Atabara, Sudan., Badi S; Department of Clinical Pharmacy, Faculty of Pharmacy, Omdurman Islamic University, Khartoum, Sudan., Fathelrahman AI; Department of Clinical Pharmacy, College of Pharmacy, Taif University, Kingdom of Saudi Arabia., Ahmed M; College of Medicine, Ajman University, Ajman, United Arab Emirates; Center of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates., Ahmed MH; Department of Medicine and HIV Metabolic Clinic, Milton Keynes University Hospital NHS Foundation Trust, Eaglestone, Milton Keynes, Buckinghamshire, UK. Electronic address: Mohamed.Hassan-Ahmed@mkuh.nhs.uk.
Jazyk: angličtina
Zdroj: Diabetes & metabolic syndrome [Diabetes Metab Syndr] 2023 Mar; Vol. 17 (3), pp. 102743. Date of Electronic Publication: 2023 Mar 12.
DOI: 10.1016/j.dsx.2023.102743
Abstrakt: Background: Ramadan is a holy month for Muslims. The aim of this study was to assess risk associated with Ramadan fasting among Sudanese individuals with diabetes (high, moderate, and low risk) according to International Diabetes Federation in collaboration with Diabetes and Ramadan International alliance (IDF-DAR) Practical Guidelines 2021 risk score.
Methods: This was a cross-sectional hospital-based study recruited 300 individuals with diabetes (79% have type 2 diabetes) from diabetes centers in Atbara city, the River Nile state, Sudan.
Results: The risk score was distributed as low risk (13.7%), Moderate risk (24%), and High risk (62.3%). T-test showed a significant difference in mean risk score by gender, duration and type of diabetes (p values = 0.004, 0.000, & 0.000, respectively). One-way ANOVA revealed a statistically significant difference in the risk score by age groups (p = 0.000). Logistic regression revealed that the odds of being in the 41-60 years age group had lower probability to be categorized in the moderate risk group of fasting rather than low risk by 4.3 times than being in the age more than 60 years. (p = 0.008), the odds of being in the age group 41-60 years lower probability to be categorized in the high risk of fasting rather than low risk by 8 times than being in the age more than 60 years. (p = 0.000).
Conclusion: The majority of patients in this study have a high risk for Ramadan fasting. IDF-DAR risk score is of great significance in assessing individuals with diabetes for Ramadan fasting.
(Copyright © 2023. Published by Elsevier Ltd.)
Databáze: MEDLINE
Externí odkaz: